Array BioPharma Inc. and GT Advanced Technologies Inc. Analysis Reports: (NASDAQ: ARRY), (NASDAQ: GTAT)

New York, NY -- (SBWIRE) -- 04/23/2013 -- Array BioPharma Inc. (NASDAQ: ARRY) traded in the range of $5.97 and $6.56 during its latest trading session, which is also its 52 weeks high price point. The stock had opened at $5.99 and is at $6.15, up 3.19 percent from its previous close of $5.96, with above average shares volume. Array BioPharma has traded 2.1 million shares so far and its MACD chart shows bullish trend.

The company commands market capitalization of $730.30 million. Its stock is currently trading below its 20 days moving average price of $6.22. Array BioPharma develops and markets small molecule drugs. The company is based out of Colorado.

Find out more on ARRY here:
http://stockreportdaily.com/market-scan/?symbol=ARRY

GT Advanced Technologies Inc. (NASDAQ: GTAT) stock is at $3.64, up 10.94 percent from its previous close of $3.29. Its latest trading volume has been recorded at 3.04 million shares, in comparison to its average daily trading volume of 3.181 million shares. The stock has made the upward movement with high volume and thus shows bullish trend. GT Advanced Technologies is currently trading above its 20 days moving average price and 50 days moving average price of $3.60 and $3.56 respectively.

The company’s market capitalization stands at $432.60 million and its stock is highly volatile with beta of 1.70.

Find out more on GTAT here:
http://stockreportdaily.com/market-scan/?symbol=GTAT

About Stockreportdaily.com
Stockreportdaily.com issues momentum alerts on stocks that can provide gains to day traders. Stockreportdaily.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. Stockreportdaily.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Stockreportdaily.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the Stockreportdaily.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Stockreportdaily.com

Disclosure: Stockreportdaily.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Stockreportdaily.com website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit; http://www.Stockreportdaily.com/disclaimer/

Contact Info:
George Fitz
Stock Report Daily
info@Stockreportdaily.com
347-905-5009

For more information on this press release visit: http://www.sbwire.com/press-releases/array-biopharma-inc-and-gt-advanced-technologies-inc-analysis-reports-nasdaq-arry-nasdaq-gtat-241669.htm

Media Relations Contact

George Fitz
Telephone: 347-905-5009
Email: Click to Email George Fitz
Web: http://www.Stockreportdaily.com

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here